Double the Shares, Double the Joy — Thyrocare Tech Rolls Out Bonus Shares and Dividend Amid Strong Q2 Performance

Thyrocare Technologies Ltd, a leading diagnostic and preventive healthcare provider, announced key corporate actions and quarterly earnings that reinforce its growth trajectory and commitment to shareholders. At the board meeting held recently, the company approved an interim dividend of Rs 7 per equity share alongside a landmark bonus share issuance in the ratio of 2:1. This move marks the first bonus share offering by Thyrocare, rewarding shareholders with two additional shares for every share held.

 

Dividend Declaration and Bonus Shares

 

The interim dividend of Rs 7 per share signifies a steady payout, following the company's tradition of rewarding investors with attractive dividends over the years.

 

The bonus shares issuance of 2:1 is a strategic step to enhance shareholder value, coinciding with the company’s silver jubilee and upcoming festive season celebrations, aimed at broadening equity base and investor goodwill.

 

Quarterly Financial Performance

 

Thyrocare reported consolidated operating revenue of Rs 2.17 billion for the September quarter of 2025, marking a healthy year-on-year growth of approximately 22%.

 

Consolidated net profit stood strong at Rs 479.9 million, reflecting a resilient bottom line amid evolving market dynamics.

 

Earnings before interest and taxes (EBIT) expanded significantly, showing margin improvement driven by operational efficiencies and higher service demand.

 

Market Impact and Outlook

 

The company’s stock responded positively to the announcements, maintaining steady momentum with a promising outlook from analysts projecting continued growth in revenue and profitability.

 

Thyrocare’s strategic focus on diagnostic innovations and preventive care services is expected to sustain its competitive edge, supported by favorable industry trends and increasing healthcare awareness.

 

The September quarter results and bold corporate actions underscore Thyrocare Technologies’ robust financial health and commitment to rewarding its shareholders while fostering long-term value creation.

 

Sources: NDTV Profit, CNBC TV18, Moneycontrol, BSE filings.​